Order Article Reprints

Brai A, Riva V, Clementi L, Falsitta L, Zamperini C, Sinigiani V, Festuccia C, Sabetta S, Aiello D, Roselli C, et al. Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models. Cancers. 2021; 13(21):5569. https://doi.org/10.3390/cancers13215569

Brai, Annalaura, Valentina Riva, Letizia Clementi, Lucia Falsitta, Claudio Zamperini, Virginia Sinigiani, Claudio Festuccia, Samantha Sabetta, Davide Aiello, Camilla Roselli, and et al. 2021. "Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models" Cancers 13, no. 21: 5569. https://doi.org/10.3390/cancers13215569

Brai, A., Riva, V., Clementi, L., Falsitta, L., Zamperini, C., Sinigiani, V., Festuccia, C., Sabetta, S., Aiello, D., Roselli, C., Garbelli, A., Trivisani, C. I., Maccari, L., Bugli, F., Sanguinetti, M., Calandro, P., Chiariello, M., Quaranta, P., Botta, L., ... Botta, M. (2021). Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models. Cancers, 13(21), 5569. https://doi.org/10.3390/cancers13215569